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Symptomatic intracerebral haemorrhage is a
feared complication of thrombolysis, however
bleeding can also occur at extra-cranial sites.
Case history
A 68-year-old right-handed man presented fol-
lowing an unwitnessed collapse with right-sided
weakness and speech disturbance. He was last
seen well by his wife on the morningof admission,
when leaving his house to walk his dog. He was
found collapsed by a passerby 30 minutes later
and an ambulance was called. He was face, arm,
speech test (FAST) positive.
His past medical history included hyperten-
sion, hypercholestrolaemia and throat cancer
which was treated with radiotherapy 17 years pre-
viously. He was an ex-smoker and drank up to 80
units of alcohol a week.
Onexaminationhehadanormalbloodpressure
and was in sinus rhythm. Clinically he had a left
hemispherestroke.Hewasassessedforthromboly-
sis and deemed suitable for treatment. His
National Institutes of Health Stroke Scale (NIHSS)
score was 7. A computed tomography (CT) brain
scan showed a hyperdense middle cerebral artery
with no evidence of early ischaemic changes or
haemorrhage (Figure 1). His initial bloods, includ-
ing full blood count, clotting and liver function
testswere normal:haemoglobin13.9 g/dl,platelets
446, INR1.1, PT 12s, APTT 29s, bilirubin10 umol/
L, ALT 20 iu/L and alkaline phosphatase 245 iu/L.
Hewasthrombolysedwithintravenousalteplase
four hours after onset of his stroke symptoms. Two
hours after thrombolysis was completed, he devel-
oped superﬁcial ecchymoses over his chest wall
andrightarm.Therewasnochangeinhisconscious
level and he remained haemodynamically stable.
He developed further massive haematomas over
his right shin and zygoma. His bloods were
repeated. Haemoglobin remained stable at 13 g/dl,
however as expected his clotting was abnormal:
INR 2.3, PT 27 s, APTT 39 s, with a normal ﬁbrino-
gen level (2.9 g/L; normal range 1.6–5.9 g/L). The
haematomaoverhischestwallcontinuedtoincrease
insizeto10 cmdiameter(Figure2).Despitethis,his
neurology remained stable. Following treatment
with 10 mg of vitamin K his clotting improved
(INR 1.7, PT 19 s, APTT 31 s). However, as his ﬁbri-
nogen was had fallen to 0.3 g/L and his haemo-
globin had dropped by 3 g to 10.5 g/dl, he was
given 4 units of fresh frozen plasma.
Although the subcutaneous haematomas
improved over the next 24 h, there was deterio-
ration in his higher cortical functions of language,
comprehension and neglect, with a repeat NIHSS
of 11. CT brain scan the next day showed an area
of low density in the left basal ganglia, insular
and left temporal lobe, with new haemorrhage
within the sylvian ﬁssure.
Discussion
Following the National Institute of Neurological
Disorders and Stroke (NINDS) trial there has
been an increase in the use of intravenous recom-
binant tissue Plasminogen Activator (rtPA), alte-
plase, in the treatment of acute ischaemic stroke.
1
Thrombolytic therapy has shown to be of beneﬁt
up to four hours and 30 minutes after stroke
onset, although the earlier the treatment is
started the better the outcome for patients.
2–4
Patients with stroke may present unable to give
a comprehensive history due to speech and
language disturbance and have to be assessed
quickly on clinical grounds. As much information
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1is gleaned from witnesses or family. As a result of
limb weakness, patients can be found on the ﬂoor
with no apparent injury, and this is a common
presentation in elderly patients.
Bleeding is a serious adverse effect of rtPA and
contraindications to therapy include recent
trauma. Mild trauma as a result of a collapse or
fall is often not reported by patients or relatives,
and it is only following thrombolytic treatment
that the injury becomes visible. In this case the
bleeding was signiﬁcant, causing a drop in hae-
moglobin and necessitating reversal of thromboly-
sis. As a consequence of this, his ischaemic stroke
completed. With the increasing use of alteplase in
hyperacute stroke, it is important physicians are
aware of this potential complication which can
occur from previous unrecognized minor injury.
This case highlights the importance of only
administering alteplase within a well organized
stroke service with staff trained in delivering
thrombolysis and in monitoring for any compli-
cations associated with thrombolysis.
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Figure 1
Non-contrast CT brain scan showing a hyper-
dense middle cerebral artery
Figure 2
Widespread subcutaneous haematomas in a
patient treated with rtPA
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